Following the market opening Wednesday, the Dow traded down 0.34% to 36,017.63 while the NASDAQ fell 0.19% to 15,944.13. The S&P also fell, dropping 0.23% to 4,690.06.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 48,161,370 cases with around 786,260 deaths. India confirmed a total of at least 34,466,590 cases and 464,150 deaths, while Brazil reported over 21,965,680 COVID-19 cases with 611,520 deaths. In total, there were at least 255,259,860 cases of COVID-19 worldwide with more than 5,133,290 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Consumer discretionary shares gained by 0.5% on Wednesday. Meanwhile, top gainers in the sector included Canoo Inc. GOEV, up 14% and iMedia Brands, Inc. IMBI up 11%.
In trading on Wednesday, financials shares fell 1.1%.
Top Headline
Lowe's Companies, Inc. LOW reported better-than-expected results for its third quarter on Wednesday.
Lowe's Companies posted quarterly earnings of $2.73 per share, beating analysts’ estimates of $2.35 per share. The company’s quarterly sales came in at $22.90 billion, versus expectations of $21.99 billion.
Equities Trading UP
Canoo Inc. GOEV shares shot up 19% to $12.44 after the pre-production electric vehicle startup made a series of announcements. Canoo on Monday after-hours surprised investors with a plan to begin production before the fourth quarter of 2022, compared with a previous estimate of early 2023.
Shares of Tattooed Chef, Inc. TTCF got a boost, shooting 16% to $18.54 as the company announced Q3 results.
EyePoint Pharmaceuticals, Inc. EYPT shares were also up, gaining 17% to $16.38. EyePoint Pharmaceuticals priced an underwritten public offering of 4.03 million at $13.75 per share and pre-funded warrants to purchase up to an aggregate of 3.27 million shares at $13.74 per pre-funded warrant.
Check out these big movers of the day
Equities Trading DOWN
StoneCo Ltd. STNE shares tumbled 28% to $22.79 after the company reported worse-than-expected Q3 earnings.
Shares of Cyclo Therapeutics, Inc. CYTH were down 23% to $5.67. Cyclo Therapeutics priced its previously announced underwritten public offering of 1.95 million shares at $6.00 per share, with gross proceeds of $11.7 million.
PAVmed Inc. PAVM was down, falling 21% to $3.8999. PAVme and Lucid Diagnostics see Q3 EsoGuard related revenue of 200,000 and GAAP loss of $0.15 per share.
Commodities
In commodity news, oil traded down 1.1% to $79.85, while gold traded up 0.4% to $1,861.90.
Silver traded up 0.8% Wednesday to $25.13 while copper fell 1.8% to $4.2740.
Euro zone
European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.1%, the Spanish Ibex Index fell 0.2% and the German DAX 30 gained 0.1%. Meanwhile, the London’s FTSE 100 fell 0.4%, French CAC 40 rose 0.1% and Italy’s FTSE MIB rose 0.1%.
Annual inflation rate in the UK surged to 4.2% in October, recording the highest level since December 2011. The headline rate of output prices in the UK increased to 8.0% year-over-year in October.
Economics
Housing starts dropped 0.7% to an annualized rate of 1.52 million in October, while building permits climbed 4% from a month ago to an annual rate of 1.650 million.
The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is scheduled for release at 10:30 a.m. ET.
Federal Reserve Bank of Cleveland President Loretta Mester will speak at 11:20 a.m. ET.
San Francisco Federal Reserve Bank President Mary Daly is set to speak at 12:40 p.m. ET.
Federal Reserve Governor Christopher Waller will speak at 12:40 p.m. ET.
Federal Reserve Bank of Cleveland President Loretta Mester is set to speak at 12:40 p.m. ET.
The Treasury is set to auction 20-year bonds at 1:00 p.m. ET.
Federal Reserve Bank of Chicago President Charles Evans will speak at 4:05 p.m. ET.
Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 4:10 p.m. ET.
Check out the full economic calendar here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.